CalciMedica Inc., a La Jolla, Calif.-based drug startup focused on autoimmune and inflammatory diseases, has secured $4 million of a $12 million Series C round, according to a regulatory filing. Backers include Biogen Idec, Sanderling Ventures and S.R. One Ltd. www.calcimedica.com